PTX-100

PTX-100 · Prescient Therapeutics Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PTX-100, covering 2025-09-02 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL [Phase 2]